{"type":"video","version":"1.0","provider_name":"Dailymotion","provider_url":"https:\/\/www.dailymotion.com","title":"Pfizer permitir\u00e1 fabricar a otros su p\u00edldora experimental contra la COVID-19","description":"La farmac\u00e9utica estadounidense otorgar\u00e1 una licencia al Fondo de Patentes de Medicamentos, con sede en Ginebra, lo que permitir\u00e1 a las compa\u00f1\u00edas de gen\u00e9ricos producir la p\u00edldora antiviral para su uso en 95 pa\u00edses. Esto representa el 53% de la poblaci\u00f3n mundial.","author_name":"euronews (en espa\u00f1ol)","author_url":"https:\/\/www.dailymotion.com\/euronews-es","width":480,"height":269,"html":"<iframe frameborder=\"0\" width=\"480\" height=\"269\" src=\"https:\/\/geo.dailymotion.com\/player.html?video=x85l00a&\" allowfullscreen allow=\"autoplay; fullscreen; picture-in-picture; web-share\"><\/iframe>","thumbnail_url":"https:\/\/s2.dmcdn.net\/v\/TP3XA1gRewUUNwEQy\/x720","thumbnail_width":1281,"thumbnail_height":720}